Outcome of patients with chronic myeloid leukemia and a low-risk score: allogeneic hematopoietic stem cell transplantation in the era of targeted therapy. A report from the EBMT Chronic Malignancies Working Party.

Koenecke, CHeim, Dvan Biezen, AHeuser, MAljurf, MKyrcz-Krzemien, SVolin, Lde Souza, C AGedde-Dahl, TSengeloev, HSchanz, UKomarnicki, MArroyo, C HTholouli, EGluckman, EEsquirol, AYakoub-Agha, IGürman, GOlavarria, EKröger, N2023-01-252023-01-252016-04-25http://hdl.handle.net/10668/10021enAdolescentAdultAlgorithmsChildDecision MakingFemaleHematopoietic Stem Cell TransplantationHumansLeukemia, Myelogenous, Chronic, BCR-ABL PositiveMaleMiddle AgedMolecular Targeted TherapyRisk AssessmentTransplantation, HomologousTreatment OutcomeYoung AdultOutcome of patients with chronic myeloid leukemia and a low-risk score: allogeneic hematopoietic stem cell transplantation in the era of targeted therapy. A report from the EBMT Chronic Malignancies Working Party.research article2711104110.1038/bmt.2016.971476-5365